Investigated for use/treatment in anthrax exposure, bacterial infection, crohn's disease, and graft versus host disease.

Investigated for use/treatment in cystic fibrosis, diet and nutrition, pancreatic disorders, and pediatric indications.

Investigated for use/treatment in breast cancer.

Investigated for use/treatment in atherosclerosis, coronary artery disease, and vascular diseases.

Investigated for use/treatment in neuropathy (diabetic) and pain (acute or chronic).

Investigated for use/treatment in cardiovascular disorders and thrombosis.

Investigated for use/treatment in melanoma.

Investigated for use/treatment in hyperlipidemia.

Investigated for use/treatment in alzheimer's disease and neurologic disorders.

Investigated for use/treatment in growth hormone deficiencies/abnormalities and metabolic disease.

Investigated for use/treatment in cancer/tumors (unspecified).

Thrombopoietin receptor agonists are pharmaceutical agents that stimulate platelet production in the bone marrow. In this, they differ from the previously discussed agents that act...

Indicated as an adjunct therapy in the treatment of adult HIV-1 infections resistant to therapy with other NNRTIs and antiretroviral agents.

For the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.